Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes

OBJECTIVES: Dipeptidyl peptidase 4 inhibitor (DPP4i) use potentially slows the progression of diabetic kidney disease, but its effects on the risk of acute kidney injury (AKI) are unclear. We aimed to assess the association between DPP4i use and incident AKI episodes from a nationally representative...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Chia-Ter, Wang, Jui, Wu, Hon-Yen, Chien, Kuo-Liong, Hung, Kuan-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581090/
https://www.ncbi.nlm.nih.gov/pubmed/28881791
http://dx.doi.org/10.18632/oncotarget.18081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581090/
https://www.ncbi.nlm.nih.gov/pubmed/28881791
http://dx.doi.org/10.18632/oncotarget.18081

Ejemplares similares